Key facts
- This page summarizes Michael S. Urdea's Form 4 filing for PRESSURE BIOSCIENCES INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jun 2022, 16:48.
Michael S. Urdea - 24 Jun 2022 Form 4 Insider Report for PRESSURE BIOSCIENCES INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 24 Jun 2022
- Net transaction value
- +$1,014
- SEC form
- 4
- Accepted by SEC
- 28 Jun 2022, 16:48:23 UTC
- Prior SEC filing
- 03 May 2022
- Next SEC filing
- 02 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael S Urdea
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael S. Urdea filed Form 4 for PRESSURE BIOSCIENCES INC on 28 Jun 2022.
Change
- Previous filing in this sequence was filed on 03 May 2022.
- Current net transaction value: +$1,014.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PBIO
transaction
Common Stock
Other
- Transaction value
- $1,014
- Shares
- +531
- Change %
- +2.7%
- Price
- $1.91*
- Shares after
- 20,352
- Date
- 24 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Interest on convertible preferred stock paid in shares of common stock.